Company Filing History:
2 out of 55 
1 out of 3 Years Active: 2002-2009
Title: The Innovations of Michael Schranz
Introduction
Michael Schranz is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporins. With a total of 3 patents to his name, his work has had a considerable impact on antibacterial treatments.
Latest Patents
Among his latest patents is a compound of formula wherein the substituents have various meanings, useful as a pharmaceutical. Additionally, he has developed antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates. These innovations showcase his dedication to advancing medical science.
Career Highlights
Throughout his career, Michael Schranz has worked with prominent companies such as Biochemie Gesellschaft M.b.h and Nabriva Therapeutics Forschungs Gmbh. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Michael has collaborated with esteemed colleagues, including Gerd Ascher and Josef Wieser. These partnerships have further enhanced his research and development efforts.
Conclusion
Michael Schranz's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of effective antibacterial treatments.